Provider mergers and medical trend

If medical trend keeps surprising you, look at the provider market.

Mergers don’t just change healthcare. They directly impact employer sponsored plans.

Hospital mergers get sold on two promises: lower costs and better quality.

Thirty years of research says neither one holds up.

A Penn LDI review summarizing decades of studies found no rigorous evidence that hospital mergers improve quality on measurable metrics like mortality, complications, or patient experience. In some cases, quality got worse. The incentive problem is straightforward: when a system gains pricing power, it has less reason to compete on quality.

The cost side is clearer. As hospital systems have grown to control well over 90% of acute care beds, consolidation that reduces local competition consistently raises prices.

And those price increases don’t stay “in healthcare.” They come from your bottom line. They take your employees.

When hospital prices rise, employer-sponsored premiums rise across the workforce. Every employee becomes more expensive to employ at roughly the same rate. For lower-wage workers, that premium is a larger share of total compensation. So when something has to give, headcount is often the release valve.

That’s why some of the most important healthcare reform happening right now isn’t in Congress. It’s in antitrust enforcement.

Last month, the DOJ sued New York-Presbyterian, alleging contract terms that blocked insurers and employers from offering lower-cost plans that limit or exclude NYP, including through tiering and steering. That’s a direct attack on plan design flexibility.

Plan sponsors, particularly large non-hospital employers,have more at stake in local hospital market structure than most realize. The impact of anticompetitive behavior and the tools to fight it belong in the same conversation as your renewal.